These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19507803)

  • 21. Prospective survey of patient-controlled epidural analgesia with bupivacaine and hydromorphone in 3736 postoperative orthopedic patients.
    Liu SS; Bieltz M; Wukovits B; John RS
    Reg Anesth Pain Med; 2010; 35(4):351-4. PubMed ID: 20607876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized Trial of Intravenous Lidocaine Versus Hydromorphone for Acute Abdominal Pain in the Emergency Department.
    Chinn E; Friedman BW; Naeem F; Irizarry E; Afrifa F; Zias E; Jones MP; Pearlman S; Chertoff A; Wollowitz A; Gallagher EJ
    Ann Emerg Med; 2019 Aug; 74(2):233-240. PubMed ID: 30819520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized clinical trial of an intravenous hydromorphone titration protocol versus usual care for management of acute pain in older emergency department patients.
    Chang AK; Bijur PE; Davitt M; Gallagher EJ
    Drugs Aging; 2013 Sep; 30(9):747-54. PubMed ID: 23846749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploratory study on association of single-nucleotide polymorphisms with hydromorphone analgesia in ED.
    Xia S; Persaud S; Birnbaum A
    Am J Emerg Med; 2015 Mar; 33(3):444-7. PubMed ID: 25576257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective multicentre study to evaluate the efficacy and tolerability of osmotic release oral system (OROS) hydromorphone in opioid-naive cancer patients: Results of the Korean South West Oncology Group study.
    Song EK; Shim H; Han HS; Sun D; Lee SI; Kang MH; Lee K; Cho D; Cho IS; Park SY; Kim S; Yim CY
    Pain Res Manag; 2015; 20(6):293-9. PubMed ID: 26474382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine.
    Beatty NC; Arendt KW; Niesen AD; Wittwer ED; Jacob AK
    J Clin Anesth; 2013 Aug; 25(5):379-383. PubMed ID: 23965210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized clinical trial of the 2 mg hydromorphone bolus protocol versus the "1+1" hydromorphone titration protocol in treatment of acute, severe pain in the first hour of emergency department presentation.
    Chang AK; Bijur PE; Lupow JB; Gallagher EJ
    Ann Emerg Med; 2013 Oct; 62(4):304-10. PubMed ID: 23694801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized clinical trial of nebulized fentanyl citrate versus i.v. fentanyl citrate in children presenting to the emergency department with acute pain.
    Miner JR; Kletti C; Herold M; Hubbard D; Biros MH
    Acad Emerg Med; 2007 Oct; 14(10):895-8. PubMed ID: 17898251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous opioid dosing and outcomes in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Am J Emerg Med; 2010 Nov; 28(9):1041-1050.e6. PubMed ID: 20825766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of morning vs. evening dosing of extended-release hydromorphone on sleep physiology in patients with low back pain: a pilot study.
    Webster LR; Smith MD; Mackin S; Iverson M
    Pain Med; 2015 Mar; 16(3):460-71. PubMed ID: 25279807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized Clinical Trial of Intravenous (IV) Acetaminophen as an Adjunct to IV Hydromorphone for Acute Severe Pain in Emergency Department Patients.
    Bijur PE; Friedman BW; White D; Wollowitz A; Campbell C; Jones MP; Chang AK; Gallagher EJ
    Acad Emerg Med; 2020 Aug; 27(8):717-724. PubMed ID: 32077553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does initial hydromorphone relieve pain best if dosing is fixed or weight based?
    Xia S; Choe D; Hernandez L; Birnbaum A
    Ann Emerg Med; 2014 Jun; 63(6):692-8.e4. PubMed ID: 24210367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients.
    Bijur PE; Schechter C; Esses D; Chang AK; Gallagher EJ
    J Pain; 2006 Feb; 7(2):75-81. PubMed ID: 16459272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain.
    Binsfeld H; Szczepanski L; Waechter S; Richarz U; Sabatowski R
    Pain Pract; 2010; 10(5):404-15. PubMed ID: 20384968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot evaluation of a hydromorphone dose substitution policy and the effects on patient safety and pain management.
    Ricket A; Mateyoke G; Vallabh M; Owen C; Peppin J
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):120-4. PubMed ID: 26095481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoclonus as an acute complication of low-dose hydromorphone in multiple system atrophy.
    Hofmann A; Tangri N; Lafontaine AL; Postuma RB
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):994-5. PubMed ID: 16844959
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: pooled analysis of 13 studies.
    Hale ME; Wallace MS; Taylor DR; Kutch M; Nalamachu S
    J Opioid Manag; 2012; 8(5):299-314. PubMed ID: 23247907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study.
    Wallace M; Rauck RL; Moulin D; Thipphawong J; Khanna S; Tudor IC
    Int J Clin Pract; 2007 Oct; 61(10):1671-6. PubMed ID: 17877652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effectiveness and safety of OROS® hydromorphone in break-through cancer pain treatment: a multicenter, prospective, open-label study in Korean patients.
    Lee KH; Kim MK; Hyun MS; Kim JY; Park KU; Song HS; Lee SA; Lee WS; Bae SH; Ryoo HM; Cho YY
    J Opioid Manag; 2012; 8(4):243-52. PubMed ID: 22941852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: a retrospective review.
    Rebel A; Sloan P; Andrykowski M
    J Opioid Manag; 2009; 5(6):331-9. PubMed ID: 20073407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.